Empagliflozin 10 MG trials for Chronic kidney disease

All Empagliflozin 10 MG trials · All Chronic kidney disease trials

Phase breakdown

Recruiting trials studying Empagliflozin 10 MG for Chronic kidney disease

• A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
  NCT06642272 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
  NCT06110130 · Phase: Phase 4 · Ages: 19 Years to 90 Years · Sex: All (male and female) · 1 location
• Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
  NCT06430684 · Phase: Early Phase 1 · Ages: 12 Years to 25 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of Empagliflozin in Hemodialysis
  NCT05786443 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Empagliflozin 10 MG for Chronic kidney disease?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.